daunorubicin has been researched along with Lysosomal Enzyme Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrieu-Abadie, N; Augé, N; Bezombes, C; Brouchet, A; Jaffrézou, JP; Laurent, G; Levade, T; Medin, JA; Salvayre, R; Ségui, B; Uro-Coste, E | 1 |
Burek, C; Harzer, K; Koch, HG; Los, M; Roth, J; Schulze-Osthoff, K | 1 |
2 other study(ies) available for daunorubicin and Lysosomal Enzyme Disorders
Article | Year |
---|---|
Stress-induced apoptosis is not mediated by endolysosomal ceramide.
Topics: Apoptosis; CD40 Antigens; Cell Line, Transformed; Cell Survival; Ceramides; Daunorubicin; fas Receptor; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lysosomal Storage Diseases; Lysosomes; Signal Transduction; Sphingomyelins; Stress, Physiological; Tumor Necrosis Factor-alpha | 2000 |
The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cells, Cultured; Ceramides; Child, Preschool; Daunorubicin; DNA Damage; Doxorubicin; fas Receptor; Female; Fibroblasts; Galactosylgalactosylglucosylceramidase; Gamma Rays; Humans; Kinetics; Lymphocytes; Lysosomal Storage Diseases; Staurosporine | 2001 |